Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Accuracy of anterior nasal swab rapid antigen tests compared with RT-PCR for massive SARS-CoV-2 screening in low prevalence population

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Association of sickle cell trait with β-cell dysfunction and physical activity in adults living with and without HIV in Tanzania

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Dynamics of skin microbiota in shoulder surgery infections

    Research output: Contribution to journalReviewResearchpeer-review

  3. A unique case of Fusobacterium nucleatum spondylodiscitis communicating with a pleural empyema through a fistula

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The aim was to determine the accuracy of anterior nasal swab in rapid antigen (Ag) tests in a low SARS-CoV-2 prevalence and massive screened community. Individuals, aged 18 years or older, who self-booked an appointment for real-time reverse transcriptase-polymerase chain reaction (RT-PCR) test in March 2021 at a public test center in Copenhagen, Denmark were included. An oropharyngeal swab was collected for RT-PCR testing, followed by a swab from the anterior parts of the nose examined by Ag test (SD Biosensor). Accuracy of the Ag test was calculated with RT-PCR as reference. We included 7074 paired conclusive tests (n = 3461, female: 50.7%). The median age was 48 years (IQR: 36-57 years). The prevalence was 0.9%, that is, 66 tests were positive on RT-PCR. Thirty-two had a paired positive Ag test. The sensitivity was 48.5% and the specificity was 100%. This study conducted in a low prevalence setting in a massive screening set-up showed that the Ag test had a sensitivity of 48.5% and a specificity of 100%, that is, no false positive tests. The lower sensitivity is a challenge especially if Ag testing is not repeated frequently allowing this scalable test to be a robust supplement to RT-PCR testing in an ambitious public SARS-CoV-2 screening.

Original languageEnglish
JournalAPMIS - Journal of Pathology, Microbiology and Immunology
Volume130
Issue number2
Pages (from-to)95-100
Number of pages6
ISSN0903-4641
DOIs
Publication statusPublished - Feb 2022

Bibliographical note

This article is protected by copyright. All rights reserved.

    Research areas

  • COVID-19, diagnostic testing, rapid antigen test, SARS-CoV-2

ID: 69025909